Kevin Tang - May 24, 2021 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO (LJPC)

Role
Director, 10%+ Owner
Signature
/s/ Kevin Tang
Stock symbol
LJPC
Transactions as of
May 24, 2021
Transactions value $
$1,577,731
Form type
4
Date filed
5/26/2021, 04:56 PM
Next filing
Jun 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LJPC Common Stock Purchase $384K +104K +1.11% $3.68 9.51M May 24, 2021 By LP F1, F2
transaction LJPC Common Stock Purchase $361K +95.6K +1.01% $3.77 9.61M May 25, 2021 By LP F2, F3
transaction LJPC Common Stock Purchase $122K +31.8K +0.33% $3.83 9.64M May 25, 2021 By LP F2, F4
transaction LJPC Common Stock Purchase $711K +167K +1.73% $4.26 9.8M May 26, 2021 By LP F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $3.425 to $3.80. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnotes 1 and 3 through 5 herein.
F2 The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Michael Hearne is the Chief Financial Officer of La Jolla Pharmaceutical Company, as well as Chief Financial Officer of TCM. Mr. Tang and Mr. Hearne each have a pecuniary interest in the shares beneficially held by TCP.
F3 The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $3.67 to $3.90.
F4 The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $3.73 to $3.89.
F5 The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $3.77 to $4.50.